表紙
市場調查報告書
商品編碼
974400

先天性遺傳基因、染色體異常:醫療設備的開發平台評估 (2020年)

Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020

出版日期: | 出版商: GlobalData | 英文 314 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球先天性遺傳基因、染色體異常遺傳基因檢驗的相關產品 (檢查裝置、試劑等)的市場上,主要開發中產品與其臨床實驗的進展調查,產品特性比較分析 (臨床實驗的進展各階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易、事業聯盟等) 等資訊彙整,為您概述為以下內容。

目錄

第1章 目錄

第2章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第3章 先天性遺傳基因、染色體異常的遺傳基因檢驗:各企業現在臨床實驗中的開發中產品

  • 先天性遺傳基因、染色體異常遺傳基因檢驗的企業:各臨床實驗階段的開發中產品
  • 先天性遺傳基因、染色體異常遺傳基因檢驗:各臨床實驗階段的開發中產品

第4章 先天性遺傳基因、染色體異常遺傳基因檢驗:企業、產品概要

第5章 先天性遺傳基因、染色體異常遺傳基因檢驗:近來的市場趨勢

第6章 附錄

目錄
Product Code: GDME1040EPD

GlobalData's Medical Devices sector report, "Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inborn Gene or Chromosome Alterations Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inborn Gene or Chromosome Alterations Tests are the genetic tests used to detect monogenetic disorders (like Cystic Fibrosis, Haemochromatosis, Prothrombin Mutation etc), polygenetic disorders (like Asthma , Atherosclerosis, Diabetes, Hypertension, Osteoporosis, etc), chromosomal disorders (like Down's Syndrome, Edwards Syndrome etc), polymorphisms (like HLA-Typing etc).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inborn Gene or Chromosome Alterations Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2.1 Inborn Gene or Chromosome Alterations Overview

3 Products under Development

  • 3.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • 3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • 3.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • 3.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • 3.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies

  • 4.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
  • 4.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
  • Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
  • Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Cystic Fibrosis Urine Test - Product Status
  • Table 10: Cystic Fibrosis Urine Test - Product Description
  • Table 11: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Molecular Diagnostic Test - Bipolar Disorder - Product Status
  • Table 13: Molecular Diagnostic Test - Bipolar Disorder - Product Description
  • Table 14: Molecular Diagnostic Test - Depression - Product Status
  • Table 15: Molecular Diagnostic Test - Depression - Product Description
  • Table 16: Molecular Diagnostic Test - Parkinson's Disease - Product Status
  • Table 17: Molecular Diagnostic Test - Parkinson's Disease - Product Description
  • Table 18: Molecular Diagnostic Test - Schizophrenia - Product Status
  • Table 19: Molecular Diagnostic Test - Schizophrenia - Product Description
  • Table 20: AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Diagnostic Test - Hereditary Deafness - Product Status
  • Table 22: Diagnostic Test - Hereditary Deafness - Product Description
  • Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status
  • Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description
  • Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: SmartPanel - Product Status
  • Table 28: SmartPanel - Product Description
  • Table 29: Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: RAD4CHD Test - Product Status
  • Table 31: RAD4CHD Test - Product Description
  • Table 32: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Diagnostic Test - IFN-Beta Resistance - Product Status
  • Table 34: Diagnostic Test - IFN-Beta Resistance - Product Description
  • Table 35: Amity University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Prenatal Screening Kit - Product Status
  • Table 37: Prenatal Screening Kit - Product Description
  • Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: PDx Pre-Symptomatic Test - Product Status
  • Table 40: PDx Pre-Symptomatic Test - Product Description
  • Table 41: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Signature CF Expand - Product Status
  • Table 43: Signature CF Expand - Product Description
  • Table 44: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: SUMO Gene Test - Type 1 Diabetes - Product Status
  • Table 46: SUMO Gene Test - Type 1 Diabetes - Product Description
  • Table 47: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status
  • Table 49: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description
  • Table 50: DNA Guided Diagnostic Test - Diabetes - Product Status
  • Table 51: DNA Guided Diagnostic Test - Diabetes - Product Description
  • Table 52: DNA Guided Diagnostic Test - Obesity - Product Status
  • Table 53: DNA Guided Diagnostic Test - Obesity - Product Description
  • Table 54: INFINITI Neural Response Panel - Product Status

List of Figures

List of Figures

  • Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials